Dow Down 1.11% Nasdaq Down 1.12%

More On ANP.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Antisense Therapeutics Ltd. (ANP.AX)

-ASX
0.11 Down 0.01(4.35%) 2:10AM EDT
Prev Close:0.12
Open:0.12
Bid:0.11
Ask:0.12
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.11 - 0.12
52wk Range:0.10 - 0.23
Volume:226,500
Avg Vol (3m):312,220
Market Cap:15.85M
P/E (ttm):N/A
EPS (ttm):-0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Antisense Therapeutics Limited develops and commercializes novel antisense therapeutics in Australia. The company’s product pipeline comprises ATL1102, an antisense inhibitor targeting VLA-4 for the treatment of multiple sclerosis and asthma;... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback